This report analyzes and evaluates the current state of the European Market for Orthopedic Biomaterials, including existing and potential markets as well as product average selling prices. Please request a Free Sample to learn more.
The European market for orthopedic materials is segmented into bone graft substitutes (BGS), which includes allograft, synthetic and demineralized bone matrices (DBM); bone morphogenetic protein (BMP) growth factors; hyaluronic acid (HA) viscosupplementation; and autologous chondrocyte implantation (ACI).
The European orthopedic biomaterials market includes bone graft substitutes (BGS), hyaluronic acid (HA) viscosupplementation injections, bone morphogenetic protein (BMP) growth factor therapy and autologous chondrocyte implantations (ACI). The HA market experienced significant contractions in 2012 and 2013 due to the extreme price competition resulting from an increase in competition, especially in Germany.
Browse more Orthopedic Market Research Reports